Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
10/2003
10/16/2003US20030195249 Crystal structured benzenesulfonic acid salts of 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol, used as sustained release antidepressants
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195173 Colchinol derivatives as angiogenesis inhibitors
10/15/2003EP1351907A1 2-butyl-3-(4- 3(dibutylamino)propoxy benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof
10/15/2003EP1351905A2 Polymerizable higher diamondoid derivatives
10/15/2003EP0907788B1 Process for the bleaching of chemical pulp
10/15/2003CN1449276A Primary intermediates for oxidative coloration of hair
10/15/2003CN1124254C Process for preparing optical-purity fluoxetine
10/14/2003US6632955 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
10/14/2003US6632543 Having m-terphenyl group; heat resistanct; bright; long life
10/14/2003CA2065476C Optically active secondary amine compound, process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using saidcompound
10/09/2003WO2003082805A1 Low water-soluble venlafaxine salts
10/09/2003WO2003082804A1 Venlafaxine besylate
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082800A1 Compounds that stimulate glucose utilization and methods of use
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191306 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
10/09/2003US20030191247 Mixtures of curable carbocyclic amines-2+ and fluoropolymers, used as seals or moldings having heat, chemical and solvent resistance
10/09/2003US20030190353 Low water-soluble venlafaxine salts
10/08/2003EP1349859A2 Triazolopyrimidines
10/08/2003EP0968171B1 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
10/08/2003CN1447815A Ruthenium complexes contg. carboids
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630509 Phenalkyloxy-phenyl derivatives
10/02/2003WO2003080561A1 Process for preparation of voglibose
10/02/2003WO2003080560A1 Manufacture of phenyl ethylamine compounds, in particular venlafaxine
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003US20030187178 Photostability; weatherproofing
10/02/2003US20030186396 Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives
10/02/2003US20030182735 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
10/01/2003EP1129055B1 Method for racemization of optically active amines
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003CN1445209A Substitutional amine-group compound applicable to reverse flotation of bauxite
09/2003
09/30/2003US6627776 Quaternary ammonium compounds and process for preparing and using same
09/30/2003US6627662 3-amino-propoxyphenyl derivatives (I)
09/30/2003US6627648 Pharmaceutical compositions and methods for use
09/25/2003WO2003078380A2 Process for preparing tramadol hydrochloride and/or tramadol momohydrate
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077874A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003WO2003010128A3 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181489 For therapy and prophylaxis of cough in warm-blooded animals
09/25/2003US20030181450 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
09/25/2003US20030181344 The photoresist stripping composition of the present invention contains at least one oxymethylamine compound represented by the following formula 1: wherein R1 to R3 are as defined in the specification. Of the oxymethylamine
09/25/2003CA2478909A1 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1346978A1 Process for preparing tramadol hydrochloride and/or tramadol monohydrate
09/24/2003CN1444103A Optical photoresist stripping composition and cleaning composition
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/24/2003CN1122001C Method of separating optical isomers
09/23/2003US6624201 High purity (1r,2s,4r)-(−)-2-[(2′-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7 -tri-[methyl]-bicyclo [2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds and their use
09/23/2003US6624120 Substituted herbicidal phenyluracils
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076386A2 Catalysts and method for the production of amines
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176723 Modifying chemoselectivity during oxidation of nitrogen compounds
09/18/2003US20030176507 Optically resolving racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid using an optically active amine compound
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds
09/18/2003US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/17/2003EP1343750A1 Process for the preparation of phenethylamine derivatives
09/17/2003CN1442403A Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine
09/16/2003US6620960 Process for the preparation of substituted phenylacetonitriles
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments
09/12/2003WO2003029208A3 Method for producing vanillylamine hydrochloride
09/11/2003US20030171440 Tramadol analogs and uses thereof
09/10/2003EP1341775A2 Process for the preparation of morpholinones
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441771A Method for producing 3,3-diarylpropylamines
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003045306A3 Phenoxy amine compounds and compositions for delivering active agents
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166719 2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166487 Normally liquid, omega-hydrofluoroalkyl ether compounds (and selected mixtures thereof) have a saturated perfluoroaliphatic chain of carbon atoms interrupted by one or more ether oxygen atoms. The compounds can be prepared, by decarboxylation of
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1340802A1 Alkyl glycidyl ether-capped diamine foam controlling agents
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1339671A2 1,7 and 1,9-diarylpolymethine salts
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/02/2003US6613863 Benzyltrialkylammonium carboxylate isocyanate trimerization catalysts
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
08/2003
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003US20030163003 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
08/28/2003US20030162842 Ethoxylated triethanolamines and alkyl polyglycosides; surfactants and defoaming agents
08/28/2003US20030162840 Novel process for preparing salmeterol
08/28/2003US20030162830 3,4-diphenyl-bicyclo(4.3.0)nonyl derivatives
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 140